What is the recommended management of hyperthyroidism in adults?

Management of Hyperthyroidism in Adults

For overt hyperthyroidism from Graves' disease, methimazole is the preferred first-line antithyroid drug for 12-18 months, with radioactive iodine ablation or thyroidectomy reserved for treatment failures, relapses, or patient preference. 1

Diagnostic Confirmation and Etiology

Before initiating treatment, confirm hyperthyroidism biochemically with suppressed TSH and elevated free T4 and/or T3, then establish the underlying cause 2, 3:

• Measure TSH-receptor antibodies to diagnose Graves' disease (70% of cases) 2, 1
• Perform thyroid ultrasonography to assess for toxic nodular goiter (16% of cases) or nodules 2
• Order thyroid scintigraphy if nodules are present or etiology remains unclear 3
• Consider thyroid peroxidase antibodies and evaluate for drug-induced causes (amiodarone, tyrosine kinase inhibitors, immune checkpoint inhibitors account for 9% of cases) 2

Treatment Approach by Etiology

Graves' Disease (Primary Treatment)

Antithyroid drugs are the preferred initial therapy, specifically methimazole over propylthiouracil due to better safety profile 4, 1:

• Standard course: 12-18 months of methimazole 1
• In children: extend treatment to 24-36 months 1
• Monitor TSH-receptor antibodies at 12-18 months to assess remission likelihood 1

Predictors of recurrence after antithyroid drug discontinuation (approximately 50% recurrence rate) 2:

• Age younger than 40 years
• Free T4 ≥40 pmol/L at diagnosis
• TSH-binding inhibitory immunoglobulins >6 U/L
• Goiter size ≥WHO grade 2

For patients with high recurrence risk or persistent elevated TSH-receptor antibodies at 12-18 months, consider 2, 1:

• Long-term methimazole therapy (5-10 years) reduces recurrence to 15% versus 50% with short-term treatment 2
• Definitive treatment with radioactive iodine or thyroidectomy 4, 1

Toxic Nodular Goiter and Toxic Adenoma

Radioactive iodine ablation or thyroidectomy are the primary treatments, as antithyroid drugs rarely induce remission in autonomous nodules 2, 4:

• Radioactive iodine is most widely used in the United States 5
• Thyroidectomy should be performed by high-volume thyroid surgeons 1
• Radiofrequency ablation is an emerging option but rarely used 2

Destructive Thyroiditis

Observation with symptomatic management is appropriate, as this condition is typically mild and self-limited 2:

• Beta-blockers for symptomatic relief of palpitations and tremor
• Steroids reserved only for severe cases 2

Special Populations

Pregnancy and Women of Childbearing Age

Switch from methimazole to propylthiouracil when planning pregnancy and during the first trimester to avoid methimazole-associated embryopathy 1:

• Propylthiouracil preferred in first trimester
• Can switch back to methimazole in second and third trimesters
• Radioactive iodine is absolutely contraindicated in pregnancy 4

Graves' Ophthalmopathy (Thyroid Eye Disease)

Treatment selection must account for eye disease severity 6:

• Mild TED: Any treatment modality acceptable, but if radioactive iodine is chosen, mandatory steroid prophylaxis (short course of low-dose prednisone) is strongly recommended 6
• Moderate-to-severe active TED: Antithyroid drugs are preferred; thyroidectomy is acceptable; radioactive iodine should generally be avoided 6
• Sight-threatening TED: Control hyperthyroidism with antithyroid drugs until eye disease is treated 6

Subclinical Hyperthyroidism

Treatment is recommended for high-risk patients, particularly 3, 7:

• Age >65 years (increased risk of atrial fibrillation, osteoporosis, fractures, and dementia) 7
• Persistent TSH <0.1 mIU/L (higher risk than TSH 0.1-0.45 mIU/L) 8
• Pre-existing cardiovascular disease or osteoporosis 8, 7

Recent evidence demonstrates that normalizing TSH decreases atrial fibrillation risk 7.

Critical Monitoring and Follow-Up

• TSH and free T4 monitoring every 4-6 weeks during initial antithyroid drug titration 4
• TSH-receptor antibody measurement before discontinuing antithyroid drugs and during pregnancy 1
• For untreated subclinical hyperthyroidism, monitor every 3-12 months depending on TSH level and risk factors 9

Common Pitfalls

Methimazole hepatotoxicity versus propylthiouracil: While propylthiouracil has higher risk of severe hepatotoxicity, methimazole is preferred except in first trimester pregnancy 1.

Radioactive iodine and thyroid eye disease: Even mild or inactive eye disease warrants careful consideration and steroid prophylaxis when radioactive iodine is selected, as it carries risk of worsening ophthalmopathy 6.

Inadequate treatment duration: Stopping antithyroid drugs before 12 months significantly increases recurrence rates; extending to 24-36 months in children improves outcomes 1.